Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Oncotarget|May 19, 2018
Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEPStéphane Supiot, Loic Campion, Pascal Pommier, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2019
Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancerJihane Boustani, Eleonor Rivin Del Campo, Julie Blanc, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2016
Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecanNolwenn Dubois, Emmanuel Rio, Natacha Ripoche, et al.
Cancers|January 14, 2021
Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal CancerLoïg Vaugier, Xavier Mirabel, Isabelle Martel-Lafay, et al.
The French Journal of Urology|June 7, 2024
Kidney transplantation after pelvic radiotherapy: Increased morbidity?Marc Françot, Benoit Mesnard, Clarisse Kerleau, et al.
Cancers|April 16, 2020
Haute Couture or Ready-to-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node DetectionAnne-Victoire Michaud, Benoit Samain, Ludovic Ferrer, et al.
European Urology Oncology|May 11, 2024
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical TrialLoic Ah-Thiane, Loic Campion, Nedjla Allouache, et al.
Cancers|June 13, 2020
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal CancerMaelle Le Thiec, Aude Testard, Ludovic Ferrer, et al.
International Journal of Radiation Oncology, Biology, Physics|December 18, 2018
Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07)Loig Vaugier, Clément Palpacuer, Emmanuel Rio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2013
The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)Odré Palie, Pierre Michel, Jean-François Ménard, et al.
Pageof 4